- Latest week
- 10 Jul 2026
- Close
- 1.400000
- Fair value
- 3.337910
- Next-week expectancy
- Negative 40.34%
VVY Chart Pack
Vivoryon Therapeutics N.V.
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, VVY rose 8.95%, moving from 1.28 to 1.40. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -13.04 and has improved across the 12-week window. Market Dynamics is -0.67 on the latest week. Next-week expectancy is negative at 40.34% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 1.40
- 12-Week Change
- 8.95%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 40.34%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Below
- Relative Strength
- -13.04
- Market Dynamics
- -0.67
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 1.40
- 12-Week Change
- 8.95%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Negative 40.34%
- Signal Weeks
- 0 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Below
- Relative Strength
- -13.04
- Market Dynamics
- -0.67
Over the latest 12 completed weeks ending 2026-07-10, VVY rose 8.95%, moving from 1.28 to 1.40. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -13.04 and has improved across the 12-week window. Market Dynamics is -0.67 on the latest week. Next-week expectancy is negative at 40.34% based on similar historical setup states.
Industry Peers
Netherlands equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| PHARM Pharming Group N.V. | AMS | 10 Jul 2026 | 1.24 | 1.28 | 1.20 | 1.20 | -2.95% |